Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Fresnillo facing possible $630m bill in gold dispute - report

(Sharecast News) - Gold and silver miner Fresnillo could have to pay out $630m to a Mexican community in a long-running mining dispute, it was reported on Thursday. According to The Times, an independent review settled on the sum in January, although Fresnillo - which is disputing the amount - has yet to detail the report's findings in shareholder disclosures.

The blue chip halted operations at the Soledad-Dipolos open-pit gold mine in 2013, when a court ordered it to vacate the area in Sonora, north west Mexico.

It ruled that Fresnillo had illegally mined for gold on land that belonged to a local community, and that the gold should either be returned or the value of it paid to the people who live in the area.

The review was commissioned to establish the value of the mined gold.

According to The Times, the report has concluded that the land was granted to an agrarian community called El Bajio. It also set the value of the gold at more than $630m.

The report has been seen by both the Times and investigative journalism group SourceMaterial.

Fresnillio, which has long denied accusations of any wrongdoing or illegal activities at Soledad-Dipolos, is challenging the review, however.

The Times said chief executive Octavio Alvidrez told attendees at last week's annual general meeting that the expert opinion containing the valuation was "grossly deficient in technical and legal aspects".

He also noted the report was not a court document and was instead "merely an opinion that should aid the court".

The Times added that a hearing was due to start on Thursday to discuss the settlement.

Fresnillo, which is headquartered in Mexico and listed in London, did not immediate respond to a request to comment.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.